The U.S. House of Representatives is considering dueling proposals related to drug pricing under Medicaid and Medicare, including the Republican-led H.R. 19, the “Lower Costs, More Cures Act of 2021” and a reintroduced...more
4/26/2021
/ Biden Administration ,
Critical Infrastructure Sectors ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Healthcare Reform ,
Legislative Agendas ,
Medicaid ,
Medicaid Drug Rebate Program ,
Medicare ,
Medicare Part D ,
Patient Access ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Agenda
House committees drafted and passed their portions of the $1.9 trillion COVID-19 relief package that Democrats are preparing to pass through budget reconciliation. The reconciliation process will allow Democrats to pass the...more
2/16/2021
/ Congressional Budget Resolution ,
Coronavirus/COVID-19 ,
Financial Stimulus ,
Food Supply ,
Infectious Diseases ,
Legislative Agendas ,
Minimum Wage ,
Payroll Expenses ,
Relief Measures ,
SNAP Program ,
Tax Credits ,
Unemployment Benefits ,
Vaccinations ,
Virus Testing ,
Wage and Hour